Sun Pharma announces USFDA approval for generic Namenda® tablets	   	Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.’s Namenda 5 mg and 10 mg tablets.

Sun Pharma announces USFDA approval for generic Namenda® tablets Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Forest Laboratories, Inc.’s Namenda 5 mg and 10 mg tablets.

Sun Pharmaceuticals stocks fell 4% to Rs 672.25 following a report that the company's Halol unit had received form 483 observations from the

Sun Pharmaceuticals stocks fell 4% to Rs 672.25 following a report that the company's Halol unit had received form 483 observations from the

10 inspiring business quotes from the top 10 richest people in Asia! \m/ Rank 9 Net worth: $16.4 billion Age: 60 Country: India Industry: Pharmaceuticals Source of wealth: Self-made; Sun Pharmaceutical Industries  #Business #inspiration #motivation #life #quotes #asia #contactdb #databaseprovider #2of10

10 inspiring business quotes from the top 10 richest people in Asia! \m/ Rank 9 Net worth: $16.4 billion Age: 60 Country: India Industry: Pharmaceuticals Source of wealth: Self-made; Sun Pharmaceutical Industries #Business #inspiration #motivation #life #quotes #asia #contactdb #databaseprovider #2of10

Here’s a round-up of the stories thus far: Reuters: FDA bans imports from Sun Pharma plant in India crackdown The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd’s plant at Karkhadi in the western state of Gujarat, in the latest quality blow for India’s drug sector. …

Here’s a round-up of the stories thus far: Reuters: FDA bans imports from Sun Pharma plant in India crackdown The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd’s plant at Karkhadi in the western state of Gujarat, in the latest quality blow for India’s drug sector. …

As part of its business strategy to build a meaningful & differentiating presence in Global Oncology Therapy market, Sun Pharma,

As part of its business strategy to build a meaningful & differentiating presence in Global Oncology Therapy market, Sun Pharma,

INDIAN EQUITY MARKET OUTLOOK- 23 SEPTEMBER 2016 :Major Headlines of the day:  •	Wipro to acquire Zhonghsan Ma Er Daily Products •	Sun Pharmaceuticals among bidders for Bayer’s dermatology brands •	IOC eyes entire GSPC stake in Mundra LNG terminal

INDIAN EQUITY MARKET OUTLOOK- 23 SEPTEMBER 2016 :Major Headlines of the day: • Wipro to acquire Zhonghsan Ma Er Daily Products • Sun Pharmaceuticals among bidders for Bayer’s dermatology brands • IOC eyes entire GSPC stake in Mundra LNG terminal

Generic Sinemet (Syndopa   Tablets) a combination of Levodopa & Carbidopa  manufactured by SUN Pharmaceuticals

Generic Sinemet (Syndopa Tablets) a combination of Levodopa & Carbidopa manufactured by SUN Pharmaceuticals

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor in the U.S., in the second recall of the drug this year, the U.S. Food and Drug Administration said http://online.wsj.com/articles/sun-pharma-recalls-effexor-in-u-s-1416297616?mod=WSJ_LatestHeadlines

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor in the U.S., in the second recall of the drug this year, the U.S. Food and Drug Administration said http://online.wsj.com/articles/sun-pharma-recalls-effexor-in-u-s-1416297616?mod=WSJ_LatestHeadlines

BRAIN TUMORS, CELL PHONES, $$  - Malignant Glioma Market Poised to Expand at a Robust Pace Over 2016-2022 | Medgadget, 2.22.17 ...The major players in the Malignant Glioma Market are Sigma-Aldrich, Bristol-Myers, Genentech, Sun Pharmaceutical, Cipla, Panacea Biotec, Zydus Cadila and Merck. The largest market share is gained by the U.S, large incidence and prevalence of cases... 1 in 2 men and 1 in 3 women... almost 40% of the population are at a risk of developing cancer in coming years.

BRAIN TUMORS, CELL PHONES, $$ - Malignant Glioma Market Poised to Expand at a Robust Pace Over 2016-2022 | Medgadget, 2.22.17 ...The major players in the Malignant Glioma Market are Sigma-Aldrich, Bristol-Myers, Genentech, Sun Pharmaceutical, Cipla, Panacea Biotec, Zydus Cadila and Merck. The largest market share is gained by the U.S, large incidence and prevalence of cases... 1 in 2 men and 1 in 3 women... almost 40% of the population are at a risk of developing cancer in coming years.

Antibiotics were most commonly prescribed for lung infections (22%), urinary-tract infections (14%) and suspected infections caused by drug-resistant Staphylococcus bacteria, such as MRSA (17%).Doctors in some hospitals prescribed up to 3 times as many antibiotics as doctors other hospitals.

Antibiotics were most commonly prescribed for lung infections (22%), urinary-tract infections (14%) and suspected infections caused by drug-resistant Staphylococcus bacteria, such as MRSA (17%).Doctors in some hospitals prescribed up to 3 times as many antibiotics as doctors other hospitals.

Pinterest • The world’s catalogue of ideas
Search